UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (1), p.86-99

2017

Link zum Volltext

Verfügbarkeit prüfen

Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer

JAMA oncology, 2017-12, Vol.3 (12), p.1707

2017

Link zum Volltext

Verfügbarkeit prüfen

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

Breast cancer research and treatment, 2008-11, Vol.112 (1), p.41-52

2008

Link zum Volltext

Verfügbarkeit prüfen

The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers

Current cancer drug targets, 2015-10, Vol.15 (8), p.652

2015

Link zum Volltext

Verfügbarkeit prüfen

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures

PloS one, 2011-12, Vol.6 (12), p.e28403-e28403

2011

Link zum Volltext

Verfügbarkeit prüfen

Histotype-specific analysis of acid ceramidase expression in ovarian cancer

Virchows Archiv : an international journal of pathology, 2020-06, Vol.476 (6), p.855-862

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular differences between younger versus older ER-positive and HER2-negative breast cancers

NPJ breast cancer, 2022-11, Vol.8 (1), p.119-119, Article 119

2022

Link zum Volltext

Verfügbarkeit prüfen

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Breast cancer research : BCR, 2013-09, Vol.15 (5), p.R86-R86, Article R86

2013

Link zum Volltext

Verfügbarkeit prüfen

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation

European journal of cancer (1990), 2012-01, Vol.48 (1), p.12-23

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterization of WNT7A expression in human endometrium and endometriotic lesions

Fertility and sterility, 2007-12, Vol.88 (6), p.1534-1540

2007

Link zum Volltext

Verfügbarkeit prüfen

Identification of high risk breast-cancer patients by gene expression profiling

The Lancet (British edition), 2002-01, Vol.359 (9301), p.131-132

2002

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer

Oncogene, 1997-02, Vol.14 (5), p.543-549

1997

Link zum Volltext

Verfügbarkeit prüfen

Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1

Clinical cancer research, 2007-02, Vol.13 (4), p.1115-1122

2007

Link zum Volltext

Verfügbarkeit prüfen

PDZ-Domain-Mediated Interaction of the Eph-Related Receptor Tyrosine Kinase EphB3 and the Ras-Binding Protein AF6 Depends on the Kinase Activity of the Receptor

Proceedings of the National Academy of Sciences - PNAS, 1998-08, Vol.95 (17), p.9779-9784

1998

Link zum Volltext

Verfügbarkeit prüfen

FSCN1 as prognostic marker in borderline tumors of the ovary

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18061-e18061

2020

Link zum Volltext

Verfügbarkeit prüfen

Endometriosis may be generated by mimicking the ontogenetic development of the female genital tract

Fertility and sterility, 2007-03, Vol.87 (3), p.651-656

2007

Link zum Volltext

Verfügbarkeit prüfen

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

Genomics data, 2014-12, Vol.2 (C), p.354-356

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular classification of breast cancer patients by gene expression profiling

The Journal of pathology, 2001-10, Vol.195 (3), p.312-320

2001

Link zum Volltext

Verfügbarkeit prüfen

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

Breast cancer research : BCR, 2009-01, Vol.11 (2), p.R15-R15, Article R15

2009

Link zum Volltext

Verfügbarkeit prüfen

A clinically relevant gene signature in triple negative and basal-like breast cancer

Breast cancer research : BCR, 2011-10, Vol.13 (5), p.R97-R97, Article R97

2011

Link zum Volltext

Verfügbarkeit prüfen

The prognostic impact of age in different molecular subtypes of breast cancer

Breast cancer research and treatment, 2015-08, Vol.152 (3), p.667-673

2015

Link zum Volltext

Verfügbarkeit prüfen

EP222/#606 Acid ceramidase (ASAH1) expression is associated with improved overall survival in patients with high-grade serous ovarian cancer from the ICON-7 trial

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A139-A139

2022

Link zum Volltext

Verfügbarkeit prüfen

Low TMB as predictor for additional benefit from neoadjuvant immune checkpoint inhibition in triple-negative breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.581-581

2022

Link zum Volltext

Verfügbarkeit prüfen

Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary

Journal of clinical pathology, 2018-12, Vol.71 (12), p.1060

2018

Link zum Volltext

Verfügbarkeit prüfen

Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages

Oncogene, 2000-10, Vol.19 (42), p.4832-4839

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis

Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures

Histotype-specific analysis of acid ceramidase expression in ovarian cancer

Molecular differences between younger versus older ER-positive and HER2-negative breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation

Characterization of WNT7A expression in human endometrium and endometriotic lesions

Identification of high risk breast-cancer patients by gene expression profiling

Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer

Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1

PDZ-Domain-Mediated Interaction of the Eph-Related Receptor Tyrosine Kinase EphB3 and the Ras-Binding Protein AF6 Depends on the Kinase Activity of the Receptor

FSCN1 as prognostic marker in borderline tumors of the ovary

Endometriosis may be generated by mimicking the ontogenetic development of the female genital tract

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

Molecular classification of breast cancer patients by gene expression profiling

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

A clinically relevant gene signature in triple negative and basal-like breast cancer

The prognostic impact of age in different molecular subtypes of breast cancer

EP222/#606 Acid ceramidase (ASAH1) expression is associated with improved overall survival in patients with high-grade serous ovarian cancer from the ICON-7 trial

Low TMB as predictor for additional benefit from neoadjuvant immune checkpoint inhibition in triple-negative breast cancer

Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary

Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages

Suchergebnisse filtern